XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

Drug Discovery World

APRIL 27, 2023

The report notes that the focus on science and pharma throughout the Covid-19 pandemic has resulted in the emergence of new locations as life science hubs and name checks Boston, Massachusetts and San Francisco, California as examples of centres with heightened investment appeal in the life sciences 1.

Life Science 52

Life Science Drugs Research Gene Splicing 52

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. He has worked on Visensia, the world’s first FDA-approved multivariate patient monitoring system, and the SEND system, which is now used to monitor 20,000 patients each month in the NHS.

Clinical Trials 93

Clinical Trials Clinical Trials Trials Engineer 93

pharmaphorum

MARCH 2, 2022

There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they may be able to provide an alternative to existing mental health treatments. The latter compound has already been approved for treatment-resistance depression as the product Spravato (esketamine), after being developed by Janssen.

Life Science 100

Life Science Clinical Trials Clinical Trials Trials 100

XTalks

AUGUST 21, 2023

The FDA also issued a Rare Pediatric Disease Priority Review Voucher (PRV) to Ipsen that can be used for subsequent drug applications that would not qualify for a priority review. The FDA approval of Sohonos is a breakthrough for the US FOP community,” said Howard Mayer, head of R&D at Ipsen, in the company’s news release.

Drugs 98

Drugs FDA Approval Genetics Clinical Trials 98

XTalks

SEPTEMBER 28, 2023

While digital media, such as short video formats on social media platforms, is being adopted by many segments and industries, pharma advertising remains more traditional, with print and TV advertising continuing to be favored by pharma companies.

Drugs 105

Drugs Allergies Branding FDA Approval 105

XTalks

DECEMBER 22, 2021

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. Here is a look at some life science trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.

Life Science 98

Life Science RNA Vaccination Vaccine 98

XTalks

FEBRUARY 21, 2024

There are currently no FDA-approved drug therapies for MASH, and the disease is characterized by excess fat accumulation and inflammation in the liver, which leads to liver scarring or fibrosis. MASH is known to occur in an estimated three to five percent of adults in the US.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Insulin 59

pharmaphorum

MARCH 21, 2022

Over the past five years, medical XR companies that were smaller start-ups have evolved into multimillion-dollar enterprises, partnering with pharmaceutical companies to supply digital therapeutic solutions using 3D immersive technology. If pharma joined the event, it would undoubtedly expand the reach of these solutions.

Behavioural Health 95

Behavioural Health Pharma Companies Life Science FDA Approval 95

pharmaphorum

AUGUST 31, 2021

For the innovators and early adopters of the life sciences industry, engineering a regulatory-grade ECA can be daunting. However, if history is any indication, pharma companies have been risk-averse when it comes to fully immersing itself into the expanded use of RWE in our development efforts. About the authors.

Clinical Trials 67

Clinical Trials Clinical Trials Life Science Trials 67

pharmaphorum

JULY 8, 2022

Pharma companies have begun to explore a host of novel digital endpoints that could have far-reaching implications for accelerating drug development and adoption. It needs to be performed with a benchmark, an FDA-approved device.”. Novel digital endpoints. About the author.

Clinical Trials 81

Clinical Trials Clinical Trials Trials Regulation 81

pharmaphorum

DECEMBER 23, 2020

It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. Pharma companies have also made headway in rare diseases as several pipeline projects came to fruition. months, compared with 6.7

Marketing 77

Marketing Gene Silencing Gene Drugs 77

Cloudbyz

MAY 19, 2021

Introduction Cell and gene therapy is an upcoming wave of therapeutic innovation in the healthcare and life sciences industry and is being pragmatically accepted worldwide. The gene therapy market reported its first market approvals back in 2017 and the evolution has been extensive ever since.

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

XTalks

NOVEMBER 9, 2023

The Alinity m high risk (HR) HPV assay is approved for HPV detection and use in routine cervical cancer screening as per professional medical guidelines, explained Abbott in a press release announcing the FDA approval.

FDA Approval 64

FDA Approval HR Genotype Life Science 64

XTalks

MAY 25, 2021

Icelandic pharma company Alvotech filed a suit against AbbVie seeking to put an end to AbbVie’s monopoly over Humira amidst plans of launching its adalimumab biosimilar. In September, 2016, Amgen’s Amjevita became the first FDA-approved adalimumab biosimilar. percent internationally due to biosimilar competition.

Production 98

Production Drugs Marketing Sales 98

Delveinsight

AUGUST 4, 2021

In June 2021, Aducanumab by Biogen received FDA approval to treat patients with Alzheimer’s disease. Similarly, other companies in the domain such as Eisai/ BioArctic AB, Hoffmann-La Roche/Chugai Pharmaceuticals, Anavex Life Sciences Corp., and Neurimmune are actively working in the Alzheimer’s Therapeutics Market.

Marketing 98

Marketing Genetics Development Clinical Development 98

Pharmaceutical Technology

FEBRUARY 13, 2023

While Xcopri is a treatment for only the more common epilepsies and not rare monogenetic ones, its approval was described as somewhat of a gamechanger, notes French. SK Life Science is a subsidiary of SK, a South Korean holding company. Epidiolex is approved for Dravet Syndrome, LGS, and tuberous sclerosis complex.

Research 264

Research Gene Gene Therapy Genome 264

XTalks

MARCH 22, 2023

In October 2022, Xtalks celebrated two decades of bringing diverse stakeholders in the life science industry together through first holding physical events, then soon after, hosting exclusively online events. Just last year, the FDA approved a one-time gene therapy treatment for hemophilia B priced at $3.5

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

XTalks

JANUARY 4, 2024

Some Investigational New Drugs in Clinical Trials for Glaucoma Skye Bioscience is a pharma company dedicated to developing a synthetic cannabinoid derivative for glaucoma treatment. Furthermore, in 2022, Thea Pharma’s Iyuzeh (latanoprost ophthalmic solution) 0.005 percent was granted FDA approval for IOP reduction.

Clinical Trials 59

Clinical Trials Clinical Trials FDA Approval Trials 59

XTalks

AUGUST 17, 2020

In 2017, the US FDA approved a CAR-T cell treatment for young adults and children with B-cell ALL. Cue Biopharma has an autoimmune disease collaboration with Merck, from which early data from a type 1 diabetes program was released earlier this year by the pharma company.

Protein 98

Protein Engineer Immune Response In-Vivo 98

XTalks

MARCH 29, 2022

Jazz said the Kent Science Park site forms “the heart of our global cannabinoid manufacturing operations.”. Jazz Pharmaceuticals’ cannabidiol (CBD) drug Epidiolex became the first US Food and Drug Administration (FDA)-approved cannabis-based medication in 2018.

Medicine 111

Medicine Manufacturing Sales FDA Approval 111

XTalks

FEBRUARY 14, 2024

The moves came after a great deal of public pressure and regulatory changes, such as allowing Medicare to negotiate drug prices under the Inflation Reduction Act (IRA) and the US Food and Drug Administration (FDA) approvals of interchangeable biosimilars of insulin.

Drugs 52

Drugs Insulin Pharmacy Development 52